3D Systems Gains FDA Clearance for VSP Orthopaedics for Surgical Planning

3D Systems was granted FDA 510(k) clearance for its new VSP Orthopaedics virtual surgical planning solution, available exclusively through Onkos Surgical’s My3D™ Personalized Solutions Platform.

Surgeons can plan a tumor resection that in some cases may allow for preservation of the native joint. After an online planning session between 3D Systems’ biomedical engineers and the surgeon, patient-specific models, surgical tools and instruments are designed and 3D-printed for use within the sterile field. VSP can improve surgical accuracy and outcomes by saving time in the O.R.

Radhika Krishnan, Senior Vice President, Software & Healthcare for 3D Systems, said, “Based on the success we’ve seen with our personalized healthcare solutions in other surgical specialties, we are confident in the positive impact on patient care this technology will have for the orthopaedic community. The opportunity to leverage our capabilities with Onkos’ passion for providing differentiated solutions for oncologists will translate into meaningful innovation for musculoskeletal oncology surgeons and patients.”

“As an early stage investor in Onkos, 3D Systems understands our passion for developing innovation,” said Patrick Treacy, CEO of Onkos Surgical. “The VSP Orthopaedics System, which is available exclusively through our My3D Personalized Solutions platform, is a great example of how we’re harnessing the power of advanced surgical planning and personalization to create novel solutions that musculoskeletal patients deserve.”

Read about Onkos Surgical’s personalized precision approach to surgical oncology.

Source: 3D Systems

RELATED ARTICLES



CONTACT BONEZONE

 

CONTACT BONEZONE